Back to search
FDAFDA · Food and drugs·Recall number D-1373-2012

Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3 mg/hr), 1 patch per pouch (NDC 54092-555-01), packaged in 30-count patches per box (NDC 54092-555-30), Rx only, Manufactured for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33186.

Published June 20, 2012 · Recall initiated: July 5, 2011

Summary

FDA records drug Class II recall D-1373-2012, published June 20, 2012 and initiated July 5, 2011. Recalling firm: Noven Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 242,100 patches; Lot: Lot #: 43008, Exp 01/12; 48591, Exp 10/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Noven Pharmaceuticals, Inc.
Distributor
Nationwide and Puerto Rico.
Lot
Lot #: 43008, Exp 01/12; 48591, Exp 10/12
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3 mg/hr), 1 patch per pouch (NDC 54092-555-01), packaged in 30-count patches per box (NDC 54092-555-30), Rx only, Manufactured for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33186. recalled?

Yes. FDA published recall D-1373-2012 on June 20, 2012. Reported hazard: Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

What should I do if I have this product?

Voluntary: Firm initiated · Letter